Durvalumab with or without tremelimumab combined with particle therapy for advanced hepatocellular carcinoma with macrovascular invasion: protocol for the DEPARTURE phase Ib trial.
Sadahisa OgasawaraKeisuke KorokiHirokazu MakishimaMasaru WakatsukiAsahi TakahashiSae YumitaMiyuki NakagawaTakamasa IshinoKeita OgawaKisako FujiwaraTerunao IwanagaTakafumi SakumaNaoto FujitaRyuta KojimaHiroaki KanzakiKazufumi KobayashiSoichiro KiyonoMasato NakamuraNaoya KanogawaTomoko SaitoTakayuki KondoRyo NakagawaShingo NakamotoRyosuke MuroyamaTetsuhiro ChibaYoshihito OzawaYohei KawasakiTomoya KurokawaHideki HanaokaHiroshi TsujiNaoya KatoPublished in: BMJ open (2022)
jRCT2031210046.